InvestorsHub Logo
Followers 23
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Monday, 08/03/2020 12:13:24 PM

Monday, August 03, 2020 12:13:24 PM

Post# of 1032
COVID ARDS and ECOR Gammacore - “VNS appears as a serious candidate for a few side effect treatment that could dampen or prevent the cytokine storm observed in COVID-19 patients with severe symptoms.” https://scholar.google.com.hk/scholar?hl=en&as_sdt=0%2C33&q=vagal+stimulation+and+COVID+19&btnG=#d=gs_qabs&u=%23p%3DolcEMIow6dEJ ECOR - noninvasive VNS
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News